Design, Synthesis, and QSAR Studies of Novel Lysine Derives As Amino-Peptidase N/CD13 Inhibitors.

Qiang Wang,Maoying Chen,Huawei Zhu,Jie Zhang,Hao Fang,Binghe Wang,Wenfang Xu
DOI: https://doi.org/10.1016/j.bmc.2008.04.012
IF: 3.461
2008-01-01
Bioorganic & Medicinal Chemistry
Abstract:A series of novel L-lysine derivatives were designed, synthesized, and assayed for their inhibitory activities on amino-peptidase N(APN)/CD13 and matrix metalloproteinase-2 (MMP-2). The preliminary biological test showed that most of the compounds displayed a high inhibitory activity against MMP-2 and a low activity against APN except compound B6 which exhibited good potency (IC50 = 13.2 mu M) similar with APN inhibitor Bestatin (IC50 = 15.5 mu M), and could be used as lead compound in the future. (C) 2008 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?